Navigation Links
AMRI Signs Agreement for Exclusive License of its Tubulin Inhibitor Program for Cancer
Date:2/11/2013

ALBANY, N.Y., Feb. 11, 2013 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI's novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement follows the exercise of an option to license the intellectual property, which was granted in March 2012 by AMRI to Bessor Pharma, LLC, a translational drug development company. Chai Therapeutics is an affiliate of Bessor Pharma, LLC.

(Logo:  http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )

Under the terms of the license agreement, AMRI received an undisclosed license fee and reimbursement for certain costs associated with the intellectual property related to ALB 109564(a). Chai Therapeutics received an exclusive license to the ALB 109564(a) intellectual property, and will be solely responsible for all related research and development and patent costs going forward; AMRI will receive a share of future consideration from the further development and sales, if any, of any ALB 109564(a)-related drug that may be developed, licensed and/or commercialized.

"We are very pleased to continue to work with Bessor on the further development of AMRI's novel tubulin inhibitor," AMRI Chairman and CEO Thomas E. D'Ambra, Ph.D. said. "The recent formation of Chai Therapeutics to focus on the development of our compound is a strong statement by our partners of the potential benefit that this technology could ultimately deliver to cancer patients. Dr. Berkowitz and his team have a proven track record of success in drug development and we are confident in their ability to move this program forward."

D'Ambra continued, "The tubulin inhibitor program is an asset developed fr
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Deborah Morosini, MD Pathologist and Patient Advocate Signs on as Medical Director and Advisory Board Member of Store-A-Toothâ„¢ Dental Stem Cell Banking
2. Trade Show Display Co. GLM Displays Redesigns Blog
3. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
4. MakeSigns.com Announces New Tri-Fold Scientific Poster Service
5. Florida-Based Team Gemini Signs Recycling Facility Agreement with Solid Waste Authority of Central Ohio
6. Ben-Gurion University develops side-illuminated ultra-efficient solar cell designs
7. Bluechiip Signs Strategic Partnership with Gentris Corporation
8. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
9. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
10. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products marketed as XIAFLEX ® (collagenase clostridium ...  in the EU, announced today that it will host ... a.m. ET on Friday, March 13, 2015 to report ... and provide a corporate update. In ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Transparency Market Research ... and Other Crops - Global Industry Analysis, Size, Share, Growth, ... the global isoxaflutole market was valued at US$ 116.3 Mn ... by 2020, expanding at a CAGR of 5.1% from 2014 ... isoxaflutole stood at 2,569.5 kilo tons in 2013. , Isoxaflutole ...
(Date:3/6/2015)... Wash. , March 6, 2015   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... the Company,s fourth quarter and full year 2014 financial results ... that the Company will host a conference call and ...
(Date:3/5/2015)... March 5, 2015  DuPont (NYSE: DD ... and Industrials Conference held today in New ... L. Trerotola discussed strategy, progress and plans to ... DuPont.  Strengthening and growing the company,s leading position in ... of strategic priority for DuPont. Discussing the ...
Breaking Biology Technology:BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 2Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 3BioLife Solutions to Report Fourth Quarter and Full Year 2014 Financial Results and Provide Business Update on March 12, 2015 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4
... and SAN DIEGO, Dec. 21, 2010 Novogen Limited ... an oncology company focused on the clinical development of ... have entered into a definitive asset purchase agreement pursuant ... property portfolio in exchange for $4 million of convertible ...
... 2010 El Camino Hospital today announced its first ... El Camino Hospital is one of the first of ... trial, which is evaluating a revolutionary non-surgical, less-invasive procedure ... with severe aortic stenosis. "The Heart and ...
... Reportlinker.com announces that a new market research ... Nanobiotechnologies- applications, markets and companies ... is the creation and utilization of materials, devices, ... the nanometer-length scale (a nanometer is one billionth ...
Cached Biology Technology:Novogen and Marshall Edwards Sign Asset Purchase Agreement 2Novogen and Marshall Edwards Sign Asset Purchase Agreement 3Novogen and Marshall Edwards Sign Asset Purchase Agreement 4Novogen and Marshall Edwards Sign Asset Purchase Agreement 5El Camino Hospital Announces First Implant in Clinical Trial to Evaluate Revolutionary Heart Valve Procedure 2El Camino Hospital Announces First Implant in Clinical Trial to Evaluate Revolutionary Heart Valve Procedure 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 2Reportlinker Adds Nanobiotechnologies- applications, markets and companies 3Reportlinker Adds Nanobiotechnologies- applications, markets and companies 4Reportlinker Adds Nanobiotechnologies- applications, markets and companies 5Reportlinker Adds Nanobiotechnologies- applications, markets and companies 6Reportlinker Adds Nanobiotechnologies- applications, markets and companies 7Reportlinker Adds Nanobiotechnologies- applications, markets and companies 8Reportlinker Adds Nanobiotechnologies- applications, markets and companies 9Reportlinker Adds Nanobiotechnologies- applications, markets and companies 10Reportlinker Adds Nanobiotechnologies- applications, markets and companies 11Reportlinker Adds Nanobiotechnologies- applications, markets and companies 12Reportlinker Adds Nanobiotechnologies- applications, markets and companies 13Reportlinker Adds Nanobiotechnologies- applications, markets and companies 14Reportlinker Adds Nanobiotechnologies- applications, markets and companies 15Reportlinker Adds Nanobiotechnologies- applications, markets and companies 16Reportlinker Adds Nanobiotechnologies- applications, markets and companies 17Reportlinker Adds Nanobiotechnologies- applications, markets and companies 18Reportlinker Adds Nanobiotechnologies- applications, markets and companies 19Reportlinker Adds Nanobiotechnologies- applications, markets and companies 20Reportlinker Adds Nanobiotechnologies- applications, markets and companies 21
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... study by the University of Santiago de Compostela on Kentish ... in hydrocarbon levels along the coast of Galicia five years ... works to remove the wreck, pollution levels began to rise ... fires., On 19th November 2002 the oil tanker Prestige sank ...
... become a science in the past 25 years, but ... widespread international collaboration, broad disciplinary composition and wide geographic ... Laboratory and Indiana University. The findings, published today in ... were assembled from a review of 20,000 academic ...
... University in St. Louis paleoanthropologist Glenn Conroy, PhD, discovered the ... known pre-human ape ever found south of the equator in ... in Namibia. Traditionally, fossil-hunters often could only make educated ... chance finding the proverbial needle in a haystack. ...
Cached Biology News:Hydrocarbon pollution along the coast of Galicia shot up five years after the Prestige oil spill 2After 25 years, sustainability is a growing science that's here to stay 2Human, artificial intelligence join forces to pinpoint fossil locations 2
... 20-NW cuff pump is a dedicated cuff pump ... cuff pump replaces manual inflation and can be ... systems for mouse and rat; from single up ... 20-NW cuff pump has adjustable cut-off pressure in ...
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... AVOID FREEZE/THAW CYCLES. An assay kit designed ... Western blotting. PARP is an enzyme implicated ... apoptosis, PARP is cleaved by caspase-3. Cleavage ... to 85 kDa is a hallmark of ...
Biology Products: